LM Funding Announces Fourth Quarter and Full Year 2025 Earnings Call for March 27, 2026

Stock Information for Moleculin Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Moleculin Biotech Inc.

LM Funding America, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
LM Funding America Announces February 2026 Production and Operational Update
LM Funding America Announces January 2026 Production and Operational Update
LM Funding America Adds Additional 35 PH/s with Energization of Second Oklahoma Immersion Unit
LM Funding America Announces December 2025 Production and Operational Update
LM Funding America Announces Pricing of Registered Direct Offering for Aggregate Gross Proceeds of $6.5 Million
LM Funding America Adds 35 PH/s with Energization of First Oklahoma Immersion Unit
LM Funding America Announces November 2025 Production and Operational Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.